{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T14:13:42Z","timestamp":1758636822864,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.pcad.2021.01.002","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T19:17:49Z","timestamp":1615403869000},"page":"138-139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Editor-in-chief eight years at Progress in Cardiovascular Diseases"],"prefix":"10.1016","volume":"64","author":[{"given":"Carl J.","family":"Lavie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcad.2021.01.002_bb0005","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.pcad.2020.07.008","article-title":"Statistics 2020 at progress in cardiovascular diseases","volume":"63","author":"Lavie","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0010","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.pcad.2019.03.001","article-title":"Exercise in medicine","volume":"62","author":"Rognmo","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0015","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pcad.2019.01.002","article-title":"Cardiorespiratory fitness and cardiovascular disease: the past, present, and future","volume":"62","author":"Kaminsky","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pcad.2018.08.006","article-title":"Meta-analysis of exercise training on left ventricular ejection fraction in heart failure with reduced ejection fraction: a 10-year update","volume":"62","author":"Tucker","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0025","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pcad.2019.02.004","article-title":"Global physical activity levels: need for intervention","volume":"62","author":"Ozemek","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0030","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pcad.2019.02.007","article-title":"A role for FNDC5\/Irisin in the beneficial effects of exercise on the brain and in neurodegenerative diseases","volume":"62","author":"Young","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0035","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pcad.2019.02.003","article-title":"Are the neuroprotective effects of exercise training systemically mediated?","volume":"62","author":"Tari","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0040","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.pcad.2018.09.002","article-title":"Temporal changes in a novel metric of physical activity tracking (personal activity intelligence) and mortality: the HUNT study, Norway","volume":"62","author":"Kieffer","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pcad.2019.01.004","article-title":"Guidelines for the delivery and monitoring of high intensity interval training in clinical populations","volume":"62","author":"Taylor","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.pcad.2019.02.006","article-title":"Personal activity intelligence (PAI): a new standard in activity tracking for obtaining a healthy cardiorespiratory fitness level and low cardiovascular risk","volume":"62","author":"Nauman","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0055","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pcad.2018.12.003","article-title":"The association between the change in directly measured cardiorespiratory fitness across time and mortality risk","volume":"62","author":"Imboden","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pcad.2019.03.002","article-title":"Exercise reveals proline dehydrogenase as a potential target in heart failure","volume":"62","author":"Moreira","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0065","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pcad.2019.08.005","article-title":"Emerging strategies for diabetes and cardiovascular disorders: introduction and foreword","volume":"62","author":"Deedwania","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0070","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.pcad.2019.07.006","article-title":"An update on pharmacotherapies in diabetic dyslipidemia","volume":"62","author":"Gupta","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0075","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.pcad.2019.07.003","article-title":"Diabetes, heart failure, and renal dysfunction: the vicious circles","volume":"62","author":"Braunwald","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.pcad.2019.03.003","article-title":"Diabetic cardiomyopathy: a comprehensive updated review","volume":"62","author":"Murtaza","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0085","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.pcad.2019.08.001","article-title":"The elephant in the room: why cardiologists should stop ignoring type 2 diabetes","volume":"62","author":"O'Keefe","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0090","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pcad.2019.08.004","article-title":"Obesity, risk of diabetes and role of physical activity, exercise training and cardiorespiratory fitness","volume":"62","author":"Carbone","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0095","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.pcad.2019.07.004","article-title":"The role of coronary artery bypass surgery versus percutaneous intervention in patients with diabetes and coronary artery disease","volume":"62","author":"Godoy","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0100","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pcad.2019.07.005","article-title":"Mechanistic insights regarding the role of SGLT2 inhibitors and GLP1 agonist drugs on cardiovascular disease in diabetes","volume":"62","author":"Garg","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0105","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.pcad.2019.08.003","article-title":"Cardiovascular outcome trials of the newer anti-diabetic medications","volume":"62","author":"Acharya","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.pcad.2019.11.006","article-title":"Lipid update 2020: introduction and foreword","volume":"62","author":"Robinson","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0115","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pcad.2019.11.005","article-title":"The 2018 AHA\/ACC\/multi-society cholesterol guidelines: looking at past, present and future","volume":"62","author":"Stone","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.pcad.2019.11.007","article-title":"Impact of fitness and changes in fitness on lipids and survival","volume":"62","author":"Lavie","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0125","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.pcad.2019.10.004","article-title":"Lipid management beyond the guidelines","volume":"62","author":"Robinson","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0130","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pcad.2019.11.003","article-title":"Implications for REDUCE IT in clinical practice","volume":"62","author":"Bittner","year":"2019","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcad.2019.12.004","article-title":"Hypertension 2020 update: a view from the Crescent City and beyond","volume":"63","author":"Ferdinand","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0140","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pcad.2019.12.005","article-title":"Hypertension in African Americans: advances in community outreach and public health approaches","volume":"63","author":"Ferdinand","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0145","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.pcad.2019.12.002","article-title":"Update on hypertension in African-Americans","volume":"63","author":"Maraboto","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0150","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2019.12.003","article-title":"Contemporary concepts in access to healthcare: identification and elimination of disparities in care of minority patients","volume":"63","author":"Nasser","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0155","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pcad.2019.11.012","article-title":"Impact of therapeutic lifestyle changes in resistant hypertension","volume":"63","author":"Ozemek","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0160","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pcad.2019.11.009","article-title":"Left ventricular hypertrophy and hypertension","volume":"63","author":"Yildiz","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0165","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pcad.2020.02.011","article-title":"Prevention as treatment: a bold vision for improving the cardiovascular health of people living with HIV","volume":"63","author":"Longenecker","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0170","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pcad.2020.09.008","article-title":"Heart failure management throughout the continuum","volume":"63","author":"Ventura","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0175","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.pcad.2020.02.002","article-title":"Anticoagulation management strategies in heart transplantation","volume":"63","author":"Rizk","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0180","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.pcad.2020.03.007","article-title":"Evidence-based pharmacotherapy for prevention and management of cardiac allograft vasculopathy","volume":"63","author":"Mallah","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0185","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.pcad.2020.04.011","article-title":"Heart failure with preserved ejection fraction diagnosis and treatment: an updated review of the evidence","volume":"63","author":"Del Buono","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0190","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.pcad.2020.04.007","article-title":"Acute heart failure: more questions than answers","volume":"63","author":"Tomasoni","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0195","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.pcad.2020.09.006","article-title":"Diagnostic and prognostic considerations for use of natriuretic peptides in obese patients with heart failure","volume":"63","author":"Singh","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0200","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pcad.2020.09.005","article-title":"Implications of obesity across the heart failure continuum","volume":"63","author":"Elagizi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.pcad.2020.06.010","article-title":"The congenital bicuspid aortic valve condition in 2020","volume":"63","author":"Michelena","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pcad.2020.03.016","article-title":"Special assorted cardiovascular topics","volume":"63","author":"Lavie","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0215","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.pcad.2020.03.001","article-title":"Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis","volume":"63","author":"Lippi","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.pcad.2021.01.002_bb0220","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.pcad.2020.03.009","article-title":"Physical exercise as therapy to fight against the mental and physical consequences of COVID-19 quarantine: special focus in older people","volume":"63","author":"Jim\u00e9nez-Pav\u00f3n","year":"2020","journal-title":"Prog Cardiovasc Dis"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062021000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:18:30Z","timestamp":1758500310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062021000049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":44,"alternative-id":["S0033062021000049"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2021.01.002","relation":{},"ISSN":["0033-0620"],"issn-type":[{"type":"print","value":"0033-0620"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editor-in-chief eight years at Progress in Cardiovascular Diseases","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2021.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}